Last month, Roche announced that they are discontinuing two late-stage Phase III trials for the Alzheimer’s drug crenezumab, citing “disappointing” results.
The InvestAcure app implements spare-change investing for individuals to provide financial support for companies researching a cure to Alzheimer’s disease.
Bill Gates’ recent commitment to help establish the Alzheimer’s Diagnostic Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF), is trailblazing in many ways.
Over 10% of adults in the U.S. age 65 and older have Alzheimer’s and experts believe the number of people with the disease will continue to grow in the coming years. Millions of people hope
Max Tokarsky has made an active choice not to close his eyes. The Founder and CEO of InvestAcure is tackling a world problem head on and hopes his ingenious new app will help fund the discovery of lifesaving drugs.
In the final episode of Mad Man, Henry, distraught by Betty’s resignation to late-stage lung cancer, pleads; “what do you think they would do if Roosevelt had this?”
Not exactly true, as the founder and CEO of InvestAcure is telling anyone who will listen. A former non-profit executive-turned-evangelist for the Impact Investment and Public Benefit Corporation model,
Today at the office, we were calculating the Alzheimer’s death toll worldwide and figured out that every 38 seconds another life is claimed.
